Charlotte J. Imianowski

University of Pittsburgh — United States

Immunology and Microbiology · Life Sciences

8h-index440citations50works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(19), Immune cells in cancer(19), Immune Cell Function and Interaction(18), Cancer Cells and Metastasis(16), T-cell and B-cell Immunology(13)

Publications50 total

immgenT: A Comprehensive Reference of Convergent T-cell States in the Mouse
2026Open Access
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy
Nature Immunology·2026· 1 citedOpen Access
464 Assessing the relative and synergistic contributions of PD1 and LAG3 on CD4 <sup>+</sup> T cells in cancer
Regular and Young Investigator Award Abstracts·2025Open Access
Genomic specificity of anti-mouse TCR mAbs determined by single-cell RNAseq
The Journal of Immunology·2025Open Access
Mammary intraepithelial lymphocytes and intestinal inputs shape T cell dynamics in lactogenesis
Nature Immunology·2025· 5 citedOpen Access
Regulatory T cells in the tumour microenvironment
Nature reviews. Cancer·2025· 33 cited
Smad4 and TGFβ1 dependent gene expression signatures in conditional intestinal adenoma, organoids and colorectal cancer
Scientific Reports·2025· 1 citedOpen Access
Perturbing local steroidogenesis to improve breast cancer immunity
Nature Communications·2025· 2 citedOpen Access
Supplementary Figure 2 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2025Open Access
Supplementary Figure 3 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2025Open Access
Supplementary Figure 1 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2025Open Access
Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity
Nature·2025· 70 citedOpen Access
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Nature Microbiology·2025· 28 citedOpen Access
Supplementary Figure 1 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
Supplementary Figure 2 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
Supplementary Figure 1 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
Supplementary Figure 3 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
Supplementary Figure 2 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
Supplementary Figure 3 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
Figure 5 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Rahul Roychoudhuri(43), Sarah K. Whiteside(41), Paula Kuo(39), Alberto G. Conti(37), Jie Yang(37), Alexander C. Evans(37), Alexander J. Wesolowski(36), Benjamin I. Morris(31), Teresa von Linde(31), Edmund Poon(31), Matthew A. Lakins(31), Michelle Morrow(31), Tarrion Baird(30), Nicole E. Fletcher(30), Masahiro Yamamoto(30), Neil Brewis(30), Klaus Okkenhaug(11), Francis M. Grant(5), Panagiota Vardaka(5), Firas Sadiyah(4)